These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38795958)

  • 1. A Roadmap for Improving Medicare's Application of Coverage With Evidence Development.
    Lakdawalla D; Tunis S; Neumann P; Whicher D; Zeitler E; Liden B
    Value Health; 2024 Sep; 27(9):1191-1195. PubMed ID: 38795958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage with evidence development: where are we now?
    Zeitler EP; Gilstrap LG; Coylewright M; Slotwiner DJ; Colla CH; Al-Khatib SM
    Am J Manag Care; 2022 Aug; 28(8):382-389. PubMed ID: 35981123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare's coverage of colorectal cancer drugs: a case study in evidence development and policy.
    Carino T; Williams RD; Colbert AM; Bridger P
    Health Aff (Millwood); 2006; 25(5):1231-9. PubMed ID: 16966718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage options for promising technologies: Medicare's 'coverage with evidence development'.
    Tunis SR; Pearson SD
    Health Aff (Millwood); 2006; 25(5):1218-30. PubMed ID: 16966717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.
    Chambers JD; Chenoweth MD; Pyo J; Cangelosi MJ; Neumann PJ
    Int J Technol Assess Health Care; 2015 Jan; 31(5):347-54. PubMed ID: 26750558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value-based interventional pain management: a review of medicare national and local coverage determination policies.
    Manchikanti L; Falco FJ; Benyamin RM; Helm S; Singh V; Hirsch JA
    Pain Physician; 2013; 16(3):E145-80. PubMed ID: 23703416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forcing isolation: Medicare's "in the home" coverage standard for wheelchairs.
    Medicare Rights Center
    Care Manag J; 2005; 6(1):29-37. PubMed ID: 16447855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval.
    Neumann PJ; Crummer E; Chambers JD; Tunis SR
    Milbank Q; 2023 Dec; 101(4):1047-1075. PubMed ID: 37644739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development.
    Lindsay MJ; Siegel BA; Tunis SR; Hillner BE; Shields AF; Carey BP; Coleman RE
    AJR Am J Roentgenol; 2007 Apr; 188(4):1109-13. PubMed ID: 17377055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits.
    Otero HJ; Chambers JD; Bresnahan BW; Kamae MS; Yucel KE; Neumann PJ
    Acad Radiol; 2012 Sep; 19(9):1060-5. PubMed ID: 22748382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authority of Medicare to Limit Coverage of FDA-Approved Products: Legal and Policy Considerations.
    Daval CJR; Kesselheim AS
    JAMA Intern Med; 2023 Sep; 183(9):999-1004. PubMed ID: 37505487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How changes in the Medicare coverage process have facilitated the spread of new technologies.
    Straube BM
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-314-W5-316. PubMed ID: 15975989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare's national coverage decisions for technologies, 1999-2007.
    Neumann PJ; Kamae MS; Palmer JA
    Health Aff (Millwood); 2008; 27(6):1620-31. PubMed ID: 18997221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent proposals to limit Medigap coverage and modify Medicare cost sharing.
    Linehan K
    Issue Brief George Wash Univ Natl Health Policy Forum; 2012 Feb; (845):1-19. PubMed ID: 22420066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on locus: evolution of Medicare's local coverage policy.
    Foote SB
    Health Aff (Millwood); 2003; 22(4):137-46. PubMed ID: 12889761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Looking at CER from Medicare's perspective.
    Mohr P
    J Manag Care Pharm; 2012 May; 18(4 Suppl A):S5-8. PubMed ID: 22578211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare coverage for oncology services.
    Bagley GP; McVearry K
    Cancer; 1998 May; 82(10 Suppl):1991-4. PubMed ID: 9587095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.
    Kilian J; Stubbings J
    J Manag Care Pharm; 2007; 13(1):59-65. PubMed ID: 17269838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.